Navigation Links
ViroPharma Announces First Quarter 2013 Financial Results
Date:5/1/2013

omputing Non-GAAP

adjusted diluted net income per share

79,14785,026GAAP diluted net income (loss)  per share

$
(0.98)$
.26Non-GAAP adjusted diluted net income 

per share

$
.15$
.37 

Use of Non-GAAP Financial Measures Our "non-GAAP adjusted net income" excludes the following items from GAAP net income (loss):

  1. Non-cash interest expense: Non-GAAP adjusted net income excludes non-cash interest expense on our convertible notes.  We believe that excluding the non-cash portion of our interest expense allows management and investors an alternative view of our financial results "as if" our net income reflected only the cash portion of our interest expense. 
  2. Purchase accounting and product acquisition related adjustments:  Non-GAAP adjusted net income excludes certain items related to our acquisitions. The excluded items may include among other adjustments; charges related to amortization of intangible assets arising from acquisitions and changes in the fair value of future contingent consideration or significant transaction costs.
  3. Share-based compensation expense: Non-GAAP adjusted net income excludes the impact of our non-cash share-based compensation expense. We believe that excluding the impact of expensing share-based compensation better reflects the recurring economic characteristics of our business.

Non-GAAP net income may exclude unusual or non-recurring items that are evaluated on an individual basis. Our evaluation of whether to exclude an item for purposes of determining our non-GAAP financial measures considers both the quantitative and qualitative aspects of the item, including, among other things (i) its size and nature, (ii) whether or not it relates to our ongoing business operations, and (iii) whether or not we expect it to occur as part of our normal business on a regular basis. For purposes of determining non-GA
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. ViroPharma to Participate in Two December Healthcare Investor Conferences
2. ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results
3. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
4. VaxyGen Assay Services, LLC Announces Launch of Custom Bioassay Services and Operations
5. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
6. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
7. GeoVax Labs, Inc. Announces Nine Month 2011 Financial Results
8. WuXi PharmaTech Announces Third-Quarter 2011 Results
9. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
10. Spherix Announces Third Quarter Financial Results
11. Modern Mobility Aids, Inc. Announces November 30, 2011 Closing of Lumigene Acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... 29, 2014  The Society for Clinical Research ... program for the 9 th annual Site ... Amelia Island , Florida.  The focus on ... unchanged, however, the topics and format will allow ... among all stakeholders with a continued focus on ...
(Date:7/29/2014)... CLARA, Calif. , July 29, 2014 /PRNewswire-iReach/ ... services agreement with FORMA Therapeutics, Inc., to provide ... and proprietary fragment-based lead discovery platform for novel ... really excited about the opportunity to work with ... fields of epigenetics and protein homeostasis. FORMA Therapeutics, ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 July ... vaccine pioneer in the biotechnology industry, announced that ... Coast Securities, Inc. to explore financing opportunities that ... technology, a breakthrough vaccine platform with the potential ... The company exclusively licensed the well-established LAMP platform ...
(Date:7/29/2014)... WA (PRWEB) July 29, 2014 ... IRB services, has been awarded accreditation by the ... for its Lean Six Sigma Deployment Program. ... waste and improve performance. , Quorum’s Lean Six ... the Accredited Deployment Program designation. The designation is ...
Breaking Biology Technology:TransCelerate, Lilly, Pfizer, and FDA Highlight Collaborative Program at the Site Solutions Summit 2TransCelerate, Lilly, Pfizer, and FDA Highlight Collaborative Program at the Site Solutions Summit 3Nanosyn Announces Expanded Partnership With FORMA Therapeutics 2Immunomic Therapeutics Engages Newport Coast Securities, Inc. 2Immunomic Therapeutics Engages Newport Coast Securities, Inc. 3Quorum Review IRB Accredited by IASSC for Lean Six Sigma Deployment Program 2Quorum Review IRB Accredited by IASSC for Lean Six Sigma Deployment Program 3
... CINCINNATI, June 16, 2011 Kendle (Nasdaq: ... research organization, today announced several of its senior ... issues at the Drug Information Association (DIA) 47th ... experts will address key topics, including the benefits ...
... , New Generation of the Ziehm Vision RFD ... Imaging has launched a new generation of the Ziehm Vision,RFD ... allows it to be used over an almost unlimited period,of ... ORs.,Thanks to its mobility and significantly lower investment costs,the Ziehm ...
... 2011 NewCardio, Inc., (OTC BB: NWCI) a ... of its recent medical and technical submissions have ... Annual International Conference of the IEEE Engineering in ... The two papers: ,Wireless Monitoring of Reconstructed 12-Lead ...
Cached Biology Technology:Kendle Experts to Address Key Industry Issues at Drug Information Association 47th Annual Meeting 2Kendle Experts to Address Key Industry Issues at Drug Information Association 47th Annual Meeting 3SVS 2011: Ziehm Imaging Presents Latest Mobile C-armTechnology for Intraoperative use 2NewCardio Selected to Present at 33rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society 2NewCardio Selected to Present at 33rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society 3NewCardio Selected to Present at 33rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society 4
(Date:7/28/2014)... pinpointed a mechanism in part of the brain that is ... to both type 1 and type 2 diabetes. The findings ... of the National Academies of Sciences . , "We,ve ... part of the hypothalamus known as the ventromedial nucleus ... levels in the blood," said lead author Sabrina Diano, professor ...
(Date:7/28/2014)... The genome of Solanum pennellii , a wild ... an international group of researchers including the labs headed ... UC Davis Department of Plant Biology. The new genome ... , The work, published July 27 in the journal ... and colleagues at Aachen University in Germany. The UC ...
(Date:7/28/2014)... for Alzheimer,s disease and other forms of dementia, but ... treatment. , University of Washington bioengineers have a designed ... of the body,s normal proteins into a state that,s ... disease, Type 2 diabetes and Lou Gehrig,s disease. The ... their normal state into an abnormally folded form by ...
Breaking Biology News(10 mins):Glucose 'control switch' in the brain key to both types of diabetes 2New protein structure could help treat Alzheimer's, related diseases 2New protein structure could help treat Alzheimer's, related diseases 3
... DigitalPersona, Inc., a leader in fingerprint identity ... Solutions Company is now offering U.are.U fingerprint sensors ... modular point-of-sale (POS) workstation, the Stingray JS-950. The ... can be attached to either side of the ...
... land degradation in dryland regions continuing to worsen, ... on scientist-recommended indicators for monitoring and assessing desertification ... landmark agreement was reached after two weeks of ... attending the Ninth Session of the Conference of ...
... Israel, October 7, 2009 H2 Blocker drugs, such as ... reflux (heartburn), pose no significant risks for the fetus according ... University of the Negev. The study published in the ... the safety of the fetus when H2 blocker drugs ...
Cached Biology News:Panasonic Offers U.are.U(R) Fingerprint Sensor From DigitalPersona on Stingray JS-950 Point-of-Sale Workstations 2Satellite data instrumental in combating desertification 2Satellite data instrumental in combating desertification 3Heartburn drugs deemed safe for fetuses according to Ben-Gurion University researchers 2
Purified Mouse anti-Hu LAT (pY226) Storage Temperature: Refrigerate(2 to 8C)...
Tris-EDTA Buffer Solution, 1X, pH 8.0, sterile, Molecular Biology Grade...
... the most comprehensive, cost-effective solution to ... incorporated unprecedented quality into both our ... proven detection chemistries and antibodies that ... protocol. It also includes our competitively ...
...
Biology Products: